AGAP2 and colorectal carcinoma: It has been demonstrated that lncRNA PUNISHER “AGAP2-AS1” has a role in inducing CRC cell proliferation, epithelial-to-mesenchymal transition, and enhancement of CRC cells’ chemoresistance to gemcitabine.